Daniel Brickman

1.3k total citations
36 papers, 657 citations indexed

About

Daniel Brickman is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Otorhinolaryngology. According to data from OpenAlex, Daniel Brickman has authored 36 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Surgery and 10 papers in Otorhinolaryngology. Recurrent topics in Daniel Brickman's work include Head and Neck Cancer Studies (10 papers), Child and Animal Learning Development (6 papers) and Cancer Treatment and Pharmacology (5 papers). Daniel Brickman is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Child and Animal Learning Development (6 papers) and Cancer Treatment and Pharmacology (5 papers). Daniel Brickman collaborates with scholars based in United States, United Kingdom and Netherlands. Daniel Brickman's co-authors include Marjorie Rhodes, Daphna Oyserman, Susan A. Gelman, Neil D. Gross, Aaron Celious, Deborah Bybee, Peter E. Andersen, John P. Gleysteen, Scott H. Troob and Tyler Light and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Daniel Brickman

32 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Brickman United States 17 189 139 131 130 123 36 657
Birgit Becker Germany 18 112 0.6× 251 1.8× 133 1.0× 397 3.1× 39 0.3× 52 1.1k
Stephanie Childs United States 14 108 0.6× 57 0.4× 96 0.7× 940 7.2× 45 0.4× 20 1.4k
Jan‐Ola Östman Sweden 18 47 0.2× 42 0.3× 201 1.5× 20 0.2× 93 0.8× 59 1.3k
Juliëtte Hommes Netherlands 16 74 0.4× 26 0.2× 450 3.4× 207 1.6× 62 0.5× 53 950
Faye Antoniou Greece 11 199 1.1× 11 0.1× 47 0.4× 142 1.1× 67 0.5× 32 440
Ingo Wagner Germany 13 81 0.4× 61 0.4× 137 1.0× 100 0.8× 4 0.0× 56 586
Thomas J. Cooper Australia 13 78 0.4× 22 0.2× 30 0.2× 252 1.9× 18 0.1× 69 603
Mary Louise Z. Collins United States 12 89 0.5× 169 1.2× 59 0.5× 497 3.8× 131 1.1× 25 1.2k
Michael J. Cameron United States 18 159 0.8× 10 0.1× 130 1.0× 36 0.3× 350 2.8× 36 1.8k
William Saunders United States 15 178 0.9× 41 0.3× 26 0.2× 344 2.6× 65 0.5× 27 877

Countries citing papers authored by Daniel Brickman

Since Specialization
Citations

This map shows the geographic impact of Daniel Brickman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Brickman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Brickman more than expected).

Fields of papers citing papers by Daniel Brickman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Brickman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Brickman. The network helps show where Daniel Brickman may publish in the future.

Co-authorship network of co-authors of Daniel Brickman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Brickman. A scholar is included among the top collaborators of Daniel Brickman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Brickman. Daniel Brickman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ward, Matthew C., Roshan S. Prabhu, Jennifer Atlas, et al.. (2024). Weekly Versus Bolus Cisplatin Concurrent With Definitive Radiation Therapy for Squamous Carcinoma of the Head and Neck: A Systematic Review and Network Meta-Analysis. Practical Radiation Oncology. 14(6). e458–e466. 1 indexed citations
4.
Benatar, Michael, Terry Heiman‐Patterson, Johnathan Cooper‐Knock, et al.. (2024). Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD. Journal of Neurology Neurosurgery & Psychiatry. 96(3). 209–218. 8 indexed citations
5.
Brickman, Daniel, et al.. (2023). Enhanced Recovery After Surgery and Perioperative Laryngectomy Outcomes. The Laryngoscope. 134(5). 2262–2268. 2 indexed citations
6.
Milas, Zvonimir L., Sally J. Trufan, Jennifer H. Benbow, et al.. (2022). Survivorship Care Plans Improve the Identification of Post-radiation Hypothyroidism After Head and Neck Cancer Treatment. Anticancer Research. 42(9). 4429–4437. 3 indexed citations
7.
Broughman, James R., David D. Xiong, Benjamin J. Moeller, et al.. (2020). Rethinking the 10‐pack‐year rule for favorable human papillomavirus–associated oropharynx carcinoma: A multi‐institution analysis. Cancer. 126(12). 2784–2790. 10 indexed citations
8.
Hamilton, Erika, David M. O’Malley, Roisin E. O’Cearbhaill, et al.. (2020). Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study. Gynecologic Oncology. 158(3). 640–645. 16 indexed citations
9.
Morgensztern, Daniel, Melissa L. Johnson, Charles M. Rudin, et al.. (2020). SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 study. Lung Cancer. 145. 126–131. 19 indexed citations
10.
Hamilton, Erika, Gini F. Fleming, Premal H. Thaker, et al.. (2020). Abstract CT124: First-in-human study of SC-004, an antibody-drug conjugate targeting CLDN6/9, in patients with epithelial ovarian cancers. Cancer Research. 80(16_Supplement). CT124–CT124. 3 indexed citations
11.
Gleysteen, John P., Scott H. Troob, Tyler Light, et al.. (2017). The impact of prophylactic external carotid artery ligation on postoperative bleeding after transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. Oral Oncology. 70. 1–6. 48 indexed citations
12.
Geltzeiler, Mathew, John P. Gleysteen, Neil D. Gross, et al.. (2017). Predictors of extracapsular extension in HPV-associated oropharyngeal cancer treated surgically. Oral Oncology. 65. 89–93. 25 indexed citations
13.
Clayburgh, Daniel & Daniel Brickman. (2016). Is esophagoscopy necessary during panendoscopy?. The Laryngoscope. 127(1). 2–3. 3 indexed citations
14.
Brickman, Daniel & Neil D. Gross. (2014). Robotic Approaches to the Pharynx. Otolaryngologic Clinics of North America. 47(3). 359–372. 16 indexed citations
15.
Brickman, Daniel, et al.. (2012). Airway management after maxillectomy with free flap reconstruction. Head & Neck. 35(8). 1061–1065. 22 indexed citations
16.
Rhodes, Marjorie, Susan A. Gelman, & Daniel Brickman. (2009). Children’s attention to sample composition in learning, teaching and discovery. Developmental Science. 13(3). 421–429. 54 indexed citations
17.
Strauss, Lewis C., Oumar Sy, Justin Fairchild, et al.. (2009). Biomarker Analyses in Phase 2 Single-Agent Trials of Dasatinib for Breast Cancer.. Cancer Research. 69(24_Supplement). 2034–2034. 3 indexed citations
18.
Rhodes, Marjorie, Daniel Brickman, & Susan A. Gelman. (2008). Sample diversity and premise typicality in inductive reasoning: Evidence for developmental change. Cognition. 108(2). 543–556. 41 indexed citations
19.
Rhodes, Marjorie, Susan A. Gelman, & Daniel Brickman. (2008). Developmental Changes in the Consideration of Sample Diversity in Inductive Reasoning. Journal of Cognition and Development. 9(1). 112–143. 28 indexed citations
20.
Summers, Ronald M., et al.. (2006). Polyps: Linear and Volumetric Measurement at CT Colonography. Radiology. 241(3). 802–811. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026